Muntaner-Virgili Clara, Boronat-Cucarull Júlia, Ferreres Josep Ramon, Gamissans Marta, Marcoval Joaquim, Fernández-Calvo Davinia, Penín Rosa María, Bermejo Josep, Huesa-Barceló Lia, Manzano-Mora Sergio, Ruzafa-Martínez Eric, Bajen-Lázaro María Teresa, Benítez-Segura Ana, Notta Paula Cecilia, Jiménez-Colomo Laura, Martín-Liberal Juan, Araguas-Mora Pablo, Juárez-Lozano Marc, Linares-Galiana Isabel
Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain.
Pathology, Hospital Universitari de Bellvitge, Barcelona, Spain.
Dermatol Pract Concept. 2025 Jul 31;15(3):5134. doi: 10.5826/dpc.1503a5134.
There are few studies on the pattern of distant spread of Merkel cell carcinoma (MCC).
To analyse the most frequent locations of distant metastases from MCC and their possible relationship with the location of the primary tumour.
Patients diagnosed with cutaneous MCC between 1988 and 2022 were included in the study. The locations of the first metastases detected were recorded, both at tumour diagnosis and during follow-up after initial treatment.
One hundred patients were diagnosed with MCC. Distant metastases were detected in 31 patients (seven at diagnosis and 24 during follow-up), with a total of 52 locations: 17 non-regional lymph node metastases, 10 bone, seven liver, six lung, four non-regional cutaneous/subcutaneous, three pancreatic, two adrenal, two pharyngeal, and one mammary. No patient developed metastasis to the central nervous system. Recurrences occurred in 84% of patients before two years of follow-up. Although differences were not significant, MCCs located in the extremities tended to metastasize to extra-regional lymph nodes and those in the head and neck to bone, liver, and lung.
MCC produces metastases mainly in non-regional lymph nodes, bone, liver, and lung. Given its high frequency (1/3 of patients), we consider performing scheduled imaging tests during the first two years of follow-up advisable. Specific imaging tests for central nervous system could be reserved for patients with neurological symptoms.
关于默克尔细胞癌(MCC)远处转移模式的研究较少。
分析MCC远处转移最常见的部位及其与原发肿瘤部位的可能关系。
纳入1988年至2022年间诊断为皮肤MCC的患者。记录在肿瘤诊断时以及初始治疗后的随访期间首次检测到转移的部位。
100例患者被诊断为MCC。31例患者检测到远处转移(7例在诊断时,24例在随访期间),共52个部位:17例非区域淋巴结转移、10例骨转移、7例肝转移、6例肺转移、4例非区域皮肤/皮下转移、3例胰腺转移、2例肾上腺转移、2例咽转移和1例乳腺转移。没有患者发生中枢神经系统转移。84%的患者在随访两年前复发。尽管差异不显著,但位于四肢的MCC倾向于转移至区域外淋巴结,而位于头颈部的MCC则倾向于转移至骨、肝和肺。
MCC主要转移至非区域淋巴结、骨、肝和肺。鉴于其高发生率(占患者的1/3),我们认为在随访的前两年进行定期影像学检查是可取的。针对中枢神经系统的特定影像学检查可保留给有神经症状的患者。